Search

everythinglearnresearchcommunity

for

Search:↓

Iron deficiency is the main cause of hair loss in women, and iron supplements started within 6 months can improve hair health.

Pediatric dermatologists have varied preferences for treating alopecia areata in children, with no standard FDA-approved treatments and some using JAK inhibitors despite risks.

Experts recommend personalized treatment plans for best outcomes in managing Alopecia Areata.

Most patients with Central Centrifugal Cicatricial Alopecia at the reviewed institution were middle-aged Black women, often with no symptoms, and commonly treated with topical medications.

New treatments for hair loss include low-dose pills, updated drugs, supplements, light therapy, plasma injections, and advanced hair transplant techniques.

Assessing CD8+ T cell levels before surgery may improve vitiligo treatment outcomes.

Infrared radiation can cause skin aging and cancer at high temperatures but may have therapeutic benefits at controlled levels.

The analysis found that alopecia areata, a hair loss condition, is not very common in Australia, affecting about 0.13% of people, with new cases most often seen in males aged 19 to 34 years.

Blocking DPP4 can potentially speed up hair growth and regeneration, especially after injury or in cases of hair loss.

Minoxidil-dutasteride tattooing can potentially help regrow hair, especially in men who already have some thin hair.

New understanding and treatments for hair loss are improving, but more research is needed.

COVID-19 can cause long-term skin problems and has changed how skin doctors work.

Ixekizumab successfully treated a rare hair loss condition, leading to complete hair regrowth.

Drug repurposing speeds up drug development, saves money, and has led to about a third of new drug approvals.

Baricitinib helped most teenagers with severe hair loss regrow hair and had mild side effects.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

Low-dose oral minoxidil may help treat hair loss but is not FDA-approved and can cause side effects like unwanted hair growth and heart issues.

Hair loss is common in autoimmune diseases and can be an early sign of the condition, often requiring prompt treatment to prevent permanent damage.

Scalp microinfusion is a new method for treating hair loss that shows promise but needs more research for standardization.

Patient-reported outcomes better reflect the quality of life impact of alopecia areata than traditional severity scores.

Women with frontal fibrosing alopecia have similar vitamin D levels to those with other hair loss types, suggesting vitamin D is not a key factor in this condition.

The conclusion is that women are heavily affected by autoimmune skin diseases, face significant challenges, and need better research, treatments, and healthcare policies.

Spironolactone helps reduce fluid in the eye in Central Serous Chorioretinopathy, but doesn't improve vision and recurrence is common.

Researchers suggest using a standard question and 5-point scale to measure patient satisfaction with acne scar treatments.

Older patients with advanced kidney cancer can be managed with a drug called Sunitinib.

Lifestyle drugs are mainly used by wealthy people in India but could spread to others, affecting society and youth.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

Spironolactone is safe for breast cancer survivors with alopecia and does not increase cancer risk.

Anti-androgen therapy may boost immunity but increases injection site pain in vaccinated patients.